logo-loader
viewe-Therapeutics plc

e-therapeutics teams up with a top-five pharma company for neurodegenerative diseases project

The 12-month tie-up with the unnamed drug giant will showcase the research group's network-driven drug discovery approach

e-Therapeutics plc -
Neurodegeneration happens when there is progressive loss of structure or function of neurons and can lead to a number of debilitating diseases

e-therapeutics PLC (LON:ETX) chief executive Ray Barlow said he and his research staff were “thrilled” to be working with a “top-five” pharma company on a neurodegenerative diseases project.

The 12-month tie-up with the unnamed drug giant will see ETX’s network-driven drug discovery approach used to identify new disease pathways and small molecules that could be crucial in treating conditions such as Parkinson's, Alzheimer's and Huntington's.

Compounds resulting for e-therapeutics' work will be tested in-house.

“This deal will allow us to directly showcase our network-driven drug discovery technologies to [the pharma company] and the work has the potential to generate new therapeutic assets to add to our existing portfolio,” said CEO Barlow.

“We continue to work on a number of different types of external collaborations and look forward to sharing further news during the remainder of the year."

Neurodegeneration happens when there is progressive loss of structure or function of neurons and can lead to a number of debilitating diseases.

There are currently over one billion people globally affected by these conditions such as Parkinson’s or Alzheimers.

Quick facts: e-Therapeutics plc

Price: 3.17 GBX

AIM:ETX
Market: AIM
Market Cap: £8.53 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of e-Therapeutics plc named herein, including the promotion by the Company of e-Therapeutics plc in any Content on the Site, the Company receives...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Holding(s) in Company

1 week, 1 day ago

Holding(s) in Company

2 weeks, 4 days ago

Holding(s) in Company

2 weeks, 5 days ago

Holding(s) in Company

2 weeks, 5 days ago

Holding(s) in Company

2 weeks, 5 days ago

Half-year Report

on 10/07/2019

Holding(s) in Company

on 09/17/2019

2 min read